A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
St. Jude Children's Research Hospital
Travera Inc
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
SillaJen, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
NeoImmuneTech
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
University of California, San Diego
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boehringer Ingelheim
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Swansea Bay University Health Board
Inhibrx Biosciences, Inc
Exelixis
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CRISPR Therapeutics
Yonsei University
Yonsei University
Seattle Children's Hospital
Seattle Children's Hospital
Centre Hospitalier Universitaire de Nīmes
Massive Bio, Inc.
Thomas Jefferson University
Sichuan Baili Pharmaceutical Co., Ltd.
The First Affiliated Hospital of Zhengzhou University
Weill Medical College of Cornell University
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
West China Hospital
German Cancer Research Center
Laval University
Laval University
HiberCell, Inc.
Stanford University
Sichuan University